British Patient Capital

Quantexa develops a decision intelligence platform that unifies siloed data from various sources. Its solution provides a contextual, connected view of internal and external data to help organizations make trusted operational decisions, mitigate fraud risks, and uncover new opportunities. Established in 2016, Quantexa serves clients globally across financial services, corporate, and public sectors.

Founded in 2016, Form3 specializes in cloud-based payment processing services for regulated financial institutions. Its platform offers connectivity, payment processing, clearing, settlement, and a fully managed service model. Form3 serves a diverse range of clients including banks, non-bank financial institutions, and fintech companies.

Epsilogen Ltd is an immuno-oncology company based in London, United Kingdom, founded in 2016. The company specializes in developing immunoglobulin E (IgE) antibodies aimed at treating cancer. Epsilogen offers a portfolio of IgE candidates that specifically target cancer antigens such as HER2, EGFR, and PD-L1. Its innovative IgE platform supports the development and validation of novel antibodies, allowing for enhanced potency, improved tumor access, and a prolonged presence in tissue. This focus on IgE-based therapies positions Epsilogen to provide effective treatment options for patients with solid tumors.

Wagestream Ltd., founded in 2018 and headquartered in London, United Kingdom, develops a financial services application designed to enhance employee benefits and financial well-being. The platform allows employees to access their earned wages instantly, providing them with greater control over their pay schedules. This innovation aims to alleviate financial stress related to unexpected expenses by eliminating the need for advances, loans, and the burdens of high-interest credit or payday loans. Additionally, Wagestream offers various financial tools that help businesses support their employees in managing expenses, setting savings goals, and developing financial plans. By addressing these financial challenges, Wagestream seeks to reduce the poverty premium and prevent employees from falling into cycles of debt.

Curve Therapeutics Limited, established in 2019 and based in London, specializes in drug discovery with a focus on cancer. The company has developed an innovative screening platform that enables functional screening of diverse libraries against disease-associated targets within their native cellular environment. This platform is used to build a pipeline of novel cancer drugs targeting currently undruggable targets.

Quantexa develops a decision intelligence platform that unifies siloed data from various sources. Its solution provides a contextual, connected view of internal and external data to help organizations make trusted operational decisions, mitigate fraud risks, and uncover new opportunities. Established in 2016, Quantexa serves clients globally across financial services, corporate, and public sectors.

CyberSmart Ltd., established in 2016 and headquartered in London, specializes in designing and developing automated compliance software platforms. The company offers a suite of products, including Cyber Essentials, Cyber Essentials Plus, GDPR Ready, CyberSmart Platform, and certOS, which help businesses identify, secure, and certify security incidents. Its cloud-based dashboard manages the compliance process, while desktop applications deployed across networks monitor compliance status and detect non-conformities. Additionally, CyberSmart provides ongoing protection through regular security checks and cyber insurance coverage, targeting small to medium-sized businesses seeking to mitigate cyber threats and navigate evolving regulations.

Epsilogen Ltd is an immuno-oncology company based in London, United Kingdom, founded in 2016. The company specializes in developing immunoglobulin E (IgE) antibodies aimed at treating cancer. Epsilogen offers a portfolio of IgE candidates that specifically target cancer antigens such as HER2, EGFR, and PD-L1. Its innovative IgE platform supports the development and validation of novel antibodies, allowing for enhanced potency, improved tumor access, and a prolonged presence in tissue. This focus on IgE-based therapies positions Epsilogen to provide effective treatment options for patients with solid tumors.

AccuRx is a healthcare communication platform that connects patients and medical professionals to streamline care. The platform enables SMS messaging, appointment reminders, referrals, patient surveys, and video consultations, and supports managing virtual wards, outpatient clinics, and follow-up pathways, helping to improve efficiency in primary care. Founded in 2016 and based in London, it is used by a large majority of GP practices and NHS trusts.

Quantexa develops a decision intelligence platform that unifies siloed data from various sources. Its solution provides a contextual, connected view of internal and external data to help organizations make trusted operational decisions, mitigate fraud risks, and uncover new opportunities. Established in 2016, Quantexa serves clients globally across financial services, corporate, and public sectors.

Quantexa develops a decision intelligence platform that unifies siloed data from various sources. Its solution provides a contextual, connected view of internal and external data to help organizations make trusted operational decisions, mitigate fraud risks, and uncover new opportunities. Established in 2016, Quantexa serves clients globally across financial services, corporate, and public sectors.